CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a Phase IB/II multi-cohort study designed to evaluate the efficacy and safety of targeted agents with or without cancer immune check ...
Phase 1, Phase 2
Westwood, Kansas, United States and 20 other locations
The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer...
Phase 3
Kansas City, Missouri, United States and 188 other locations
to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitization in participants with endometrial...
Phase 2
Kansas City, Missouri, United States and 89 other locations
in participants with solid tumors.Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be remov...
Phase 1, Phase 2
Westwood, Kansas, United States and 65 other locations
The goal of the Dose Escalation phase of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity...
Phase 1
Fairway, Kansas, United States and 18 other locations
global, multi-arm study to evaluate efficacy and safety of relacorilant in combination with other treatments in patients with gynecological cancers...
Phase 2
Kansas City, Missouri, United States and 48 other locations
TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Com...
Phase 2
Kansas City, Kansas, United States and 93 other locations
-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...
Phase 1
Kansas City, Missouri, United States and 123 other locations
This is a Phase 1A/B study consisting of four parts.1. Part A (completed) is a non-randomised, open-label, sequential evaluation of the safety, pharm...
Phase 1
Fairway, Kansas, United States and 10 other locations
Phase I Study, a master protocol to investigate TCR-Engineered T cells recognizing KRAS mutations in adult subjects with Unresectable, Advanced, and/...
Phase 1
Westwood, Kansas, United States and 17 other locations
Clinical trials
Research sites
Resources
Legal